Ciprofloxacin-mediated inhibition of tenocyte migration and down-regulation of focal adhesion kinase phosphorylation

European Journal of Pharmacology

Volumn 607, Issue 1-3, 2009, Pages 23-26

  Tsai, Wen Chung ^a,b   Hsu, Chih Chin ^a,b   Chen, Huang Chung ^a,b   Hsu, Ya Hui ^a,b   Lin, Miao Sui ^a,b   Wu, Chin Wen ^a,b   Pang, Jong Hwei S ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Ciprofloxacin; Focal adhesion kinase; Tendon

Indexed keywords

CIPROFLOXACIN; FOCAL ADHESION KINASE;

ACHILLES TENDON; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL ASSAY; CELL COUNT; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; EX VIVO STUDY; EXPLANT; GROWTH INHIBITION; IN VITRO STUDY; INHIBITION KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TENOCYTE; WESTERN BLOTTING;

ACHILLES TENDON; ANIMALS; ANTI-INFECTIVE AGENTS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CIPROFLOXACIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; TENDINOPATHY; WOUND HEALING;

EID: 62149148816     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.02.006     Document Type: Article

References (32)

1. Abbi S., and Guan J.L. Focal adhesion kinase: protein interactions and cellular functions. Histol. Histopathol. 17 (2002) 1163-1171
2. Antoci Jr. V., Adams C.S., Hickok N.J., Shapiro I.M., and Parvizi J. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin. Orthop. Relat. Res. 462 (2007) 200-206
3. Bernard-Beaubois K., Hecquet C., Hayem G., Rat P., and Adolphe M. In vitro study of cytotoxicity of quinolones on rabbit tenocytes. Cell Biol. Toxicol. 14 (1998) 283-292
4. Corps A.N., Harrall R.L., Curry V.A., Fenwick S.A., Hazleman B.L., and Riley G.P. Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1 in human tendon-derived cells: a potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum. 46 (2002) 3034-3040
5. Dan M., Golomb J., Gorea A., Braf Z., and Berger S.A. Concentration of ciprofloxacin in human prostatic tissue after oral administration. Antimicrob. Agents Chemother. 30 (1986) 88-89
6. Gates R.E., King Jr. L.E., Hanks S.K., and Nanney L.B. Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture. Cell Growth Differ. 5 (1994) 891-899
7. Gilmore A.P., and Romer L.H. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesion decreases cell motility and proliferation. Mol. Biol. Cell 7 (1996) 1209-1224
8. Han E.K., Mcgonigal T., Wang J., Giranda V.L., and Luo Y. Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs. Anticancer Res. 24 (2004) 3899-3905
9. Hauck C.R., Sieg D.J., Hsia D.A., Loftus J.C., Gaarde W.A., Monia B.P., and Schlaepfer D.D. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res. 61 (2001) 7079-7090
10. Ilic D., Furuta Y., Kanazawa S., Takeda N., Sobue K., Nakatsuji N., Nomura S., Fujimoto J., Okada M., and Yamamoto T. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377 (1995) 539-544
11. Jorgensen C., Anaya J.M., Didry C., Cavovas F., Serre I., Baldet P., Ribard P., Kahn M.F., and Sany J. Arthropathies et tendinopathie achilleenne induites par la refloxacine. Rev. Rhum. 58 (1991) 623-625
12. Kato M., Takada S., Kashida Y., and Nomura M. Histological examination on Achilles tendon lesions induced by quinolone antibacterial agents in juvenile rats. Toxicol. Pathol. 23 (1995) 385-392
13. Koga F., Tsutsumi S., and Neckers L.M. Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells. Cell Cycle 6 (2007) 1393-1402
14. MacGown A.P., White L.O., Brown N.M., Lovering A.M., McMullin C.M., and Reeves D.S. Serum ciprofloxacin concentrations in patients with severe sepsis being treated with ciprofloxacin 200 mg i.v. bid irrespective of renal function. J. Antimicrob. Chemother. 33 (1994) 1051-1054
15. Mitra S.K., Hanson D.A., and Schlaepfer D.D. Focal adhesion kinase: in command and control of cell motility. Nat. Rev., Mol. Cell Biol. 6 (2005) 56-68
16. Nakamura M., Nishida T., Mishima H., and Otori T. Effects of antimicrobials on corneal epithelial migration. Curr. Eye Res. 12 (1993) 733-740
17. O'Brien M. Functional anatomy and physiology of tendons. Clin. Sports Med. 11 (1992) 505-520
18. Pai R., Szabo I.L., Giap A.Q., Kawanaka H., and Tarnawski A.S. Nonsteroidal anti-inflammatory drugs inhibit re-epithelization of wounded gastric monolayers by interfering with actin, Src, FAK, and tensin signaling. Life Sci. 69 (2001) 3055-3071
19. Parsons J.T. Focal adhesion kinase: the first ten years. J. Cell Sci. 116 (2003) 1409-1416
20. Parsons J.T., Martin K.H., Slack J.K., Taylor J.M., and Weed S.A. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19 (2000) 5606-5613
21. Pierfitte C., and Royer R.J. Tendon disorders with fluoroquinolones. Therapie 51 (1996) 419-420
22. Riu C.H. A study of staining blood film (Romanowsky system). J. Niigata Med. Assoc. 70 (1956) 635-643
23. Shah A., Lettieri J., Kaiser L., Echols R., and Heller A.H. Comparative pharmacokinetics and safety of ciprofloxacin 400 mg i.v. thrice daily versus 750 mg p.o. twice daily. J. Antimicrob. Chemother. 33 (1994) 795-801
24. Shakibaei M., and Stahlmann R. Ultrastructure of Achilles tendon from rats after treatment with fleroxacin. Arch. Toxicol. 75 (2001) 97-102
25. Sharma P., and Maffulli N. The future: rehabilitation, gene therapy, optimization of healing. Foot Ankle Clin. 10 (2005) 383-397
26. Sharma P., and Maffulli N. Biology of tendon injury: healing, modeling and remodeling. J. Musculoskelet. Neuronal Interact. 6 (2006) 181-190
27. Tsai W.C., Pang J.H.S., Hsu C.C., Chu N.K., Lin M.S., and Hu C.F. Ultrasound stimulation of types I and III collagen expression of tenocyte and upregulation of transforming growth factor. J. Orthop. Res. 24 (2006) 1310-1316
28. Tsai W.C., Hsu C.C., Tang F.T., Wong A.M.K., Chen Y.C., and Pang J.H.S. Ciprofloxacin mediated cell proliferation inhibition and G2/M cell cycle arrest in tenocytes. Arthritis Rheum. 58 (2008) 1657-1663
29. Uriarte S.M., Molestina R.E., Miller R.D., Bernabo J., Farinati A., Eiguchi K., Ramirez J.A., and Summersgill J.T. Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells. Antimicrob. Agents Chemother. 48 (2004) 2538-2543
30. Williams R.J., Attia E., Wickiewicz T.L., and Hannafin J.A. The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. Am. J. Sports Med. 28 (2000) 364-369
31. Zabraniecki L., Negrier I., Vergne P., Arnaud M., Bonnet C., Bertin P., and Treves R. Fluoroquinolone induced tendinopathy: reports of 6 cases. J. Rheumatol. 23 (1996) 516-520
32. Zagzag D., Nomura M., Friedlander D.R., Blanco C.Y., Gagner J.P., Nomura N., and Newcomb E.W. Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion. J. Cell. Physiol. 196 (2003) 394-402